Latest by Simon Collins
Activists Convince Washington Post That Pfizer Lowers Prices: Global Action Highlights Fairer Alternatives -- 'This Story Has Been Removed!'
How did the media get fooled by a fake press release? "The believability that prices could be lower and companies could still make profits accounts for the original rapid reporting," notes Simon Collins of HIV i-Base.
"As an activist living with HIV, I want decisions about my care to be supported by evidence. Jumping ahead of the data -- even with the best intentions -- has led to treatment guidelines in the past getting it wrong."
The IAS conference in Washington also included the opportunity to see two new films on early HIV activism in the U.S.
On the first evening of the conference, a few blocks south of the conference centre, a preview screening took place for a film that...
On 18 May 2012, more than 80 People Living with HIV with prominent side effects from stavudine (d4T), protested at a "Stavudine Phase-Out Festival" demanding immediate phase out of the ARV from India's National Antiretroviral Treatment (ART) program....